Abstract Convergent evidence from genetics, symptomatology, and psychopharmacology implies that there are intrinsic connections between schizophrenia (SCZ), bipolar disorder (BPD), and major depressive disorder (MDD); for example, any two or even three of these disorders could co-exist in some families. A total of 48,753 single nucleotide polymorphisms (SNPs) on chromosome 8 were genotyped by Affymetrix Genome-Wide Human SNP array 6.0 on 119 SCZ, 253 BPD (type I), 177 MDD patients, and 1000 controls. Associated SNP loci were comprehensively revealed, and outstanding susceptibility genes were identified including CSMD1, NRG1, PXDNL, SGCZ, and TMEM66. Unexpectedly, flanking genes for up to 95.9 % of the associated SNPs were replicated (P ≤ 9.9E−8) in the enlarged cohort of 986 SCZ patients. Considering convergent evidence, our results implicate that bipolar disorder and major depressive disorder might be subtypes of schizophrenia.
Introduction
Schizophrenia (SCZ[MIM 181500]) is a serious brain disorder which affects 1 % of the general population and has a strong genetic component [1] . No matter how properly and promptly treated, a proportion of SCZ patients will inevitably decline in severe chronic conditions characterized by poverty of thought, flat affect, and loss of volition. Bipolar disorder (BPD [MIM 125480] ) is characterized by alternating episodes of mania (bipolar I) or hypomania (bipolar II) interspersed with periods of depression. Major depressive disorder (MDD [MIM 608516] ) is characterized by a pervasive and persistent low mood that is accompanied by low self-esteem and by a loss of interest or pleasure in normally enjoyable activities. Convergent evidence from genetic epidemiology and molecular genetics has all indicated overlaps of genetic influences on SCZ, BPD, and MDD [2] [3] [4] [5] .
Genome-wide association study (GWAS), based on linkage disequilibrium, is an examination of many common genetic variants in different individuals to see if any variant is associated with a trait. One trend in the genetic association approach has been toward larger sample sizes for detecting causal single nucleotide polymorphisms (SNPs) that have smaller odds ratios and lower allele frequency, and another has been toward the use of strictly defined phenotypes and homogenous genetic background of the sample population. However, the accurate phenotype delineation may be more important for detecting true genetic associations than increase in sample size [6] . Over the last two decades, linkage and association studies have identified multiple chromosomal regions and candidate genes for SCZ, BPD, and MDD [7] .
The Affymetrix Genome-Wide Human SNP Array 6.0 contains more than 906,600 SNPs, and such dense resolution (approximately 3 kb) makes it possible to investigate the association of all human genes to any disease trait. However, Electronic supplementary material The online version of this article (doi:10.1007/s12035-016-0102-1) contains supplementary material, which is available to authorized users. such studies usually require large sample sizes and huge cost. Fortunately, DNA pooling constitutes a cost-effective alternative in GWAS and could cut dramatically the cost [8, 9] .
In this study, we report the results of chromosome 8 from our GWAS by Affymetrix Genome-Wide Human SNP Array 6.0 on SCZ, BPD, and MDD in the population of Shandong province of China. We also discuss the novel logical relationship between these three major mental disorders.
Materials and Methods

Subjects
The initial 119 schizophrenia patients (SCZ119) were recruited from the inpatient department of Chang Le Mental Health Center. The average age and age of onset were 33.98 ± 11.99 and 27.65 ± 7.79, respectively, and the male/ female ratio was 1.05 (61/58) . The 253 bipolar disorder patients (BPD253) were recruited from the inpatient department of Shandong Mental Health Center. The average age and age of onset were 34.05 ± 14.74 and 25.90 ± 11.77, respectively, and the male/female ratio was 1.26:1 (141/112). The 177 major depressive disorder patients (MDD177) were recruited from the inpatient department of Shandong Mental Health Center. The average age and age of onset were 44.77 ± 16.96 and 39.54 7 ± 17.04, respectively, and the male/female ratio was 0.71:1 (49/68). Another replication cohort of 986 SCZ patients (SCZ986) was mostly recruited from the inpatient department of Shandong Mental Health C e n t e r. T h e a v e r a g e a g e a n d a g e o f o n s e t w e r e 33.80 ± 11.98 and 26.04 ± 9.72, respectively, and the male/ female ratio was 0.99:1 (492/494). The 1000 normal controls were recruited from Blood Transfusion Center of Shandong Province. The average age was 23.08 ± 5.67, and the male/ female ratio was 1.32:1 (569/431). All patients and controls are Han Chinese.
The diagnoses were made according to DSM-IV criteria [10] by at least two experienced psychiatrists, on the basis of empirical diagnostic interviews. In addition, the 119 SCZ patients were also interviewed by the correspondence author (a consultant psychiatrist). Finally, all medical records were checked and diagnosis was approved by the correspondence author. Written consent was obtained from all subjects or legally authorized representative consented on the behalf of participants. This study was approved by the Ethics Committee of the Institute of Basic Medicine of Shandong Academy of Medical Sciences.
DNA Pool Construction
Genomic DNA was extracted from peripheral venous blood by a Bio-V automatic DNA extraction machine and kit (Lab-Aid 820 and 5ak021, Zhi Shan Bioscience Co., Inc., Xiamen, China). The concentration was measured twice on a NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Fisher Scientific, USA). Samples showing >10 % difference were measured again, and we used the mean of the three measurements. DNA samples were diluted to 20-ng/μl working concentrations. Five DNA pools were made for the four groups of psychiatric disorder patients and one group of controls by adding up 10 μl of each DNA sample. The first, second, third, fourth, and fifth DNA pools were made for the SCZ119, BPD253, M D D 1 7 7 , S C Z 9 8 6 , a n d N 1 0 0 0 D N A s a m p l e s , respectively.
The Affymetrix Genome-Wide Human SNP Array 6.0 Genotyping Genotyping was performed on Affymetrix Genome-Wide Human SNP 6.0 array following the manufacturer's protocol at the CapitalBio Corporation in Beijing. Sample of 1 μg of genomic DNA was equally interleaved on 96-well master plates. Quantity of double-stranded DNA was ascertained using NanoDrop 2000. Restriction enzyme digestion and PCR amplification using universal primers were performed to generate fragments of between 250 and 1100 bp in length which were further fragmented to 50-180 BPD and labeled with biotinylated nucleotides. Labeled fragments were hybridized to the microarray, washed, stained, and scanned using GeneChip® Scanner 3000 7G (Affymetrix Ltd., USA). Genotypes were called using Genotyping Console 4.1. (Affymetrix Ltd., USA)).
Individually Genotyping of rs9383046 and rs16857531 by High Resolution Melting System
In order to compare the allele frequency from the pooled DNA genotyping of Affymetrix Genome-Wide Human SNP Array 6.0, rs9383046 (Affymetrix ID, SNP_ A-4231440) in JARID2 gene was selected for individual genotyping in the 119 SCZ patients as JARID2 was previously detected as a susceptibility gene in this cohort of patients [11] . A pair of primers was designed to amplify an 88-bp segment of DNA that span rs9383046 (sense: ACTGGCTGTGTCTCACTCTT, antisense: TATTCACGTTCTTTTGCTCTTGGA). Later, rs16857531 was further individually genotyped in 117 SCZ patients of the same SCZ119 cohort (sense: ACCTAATACAAATTGGTACAGT, antisense: ACTGAAGATAATGCAAGGTT). Polymerase chain reaction (PCR) was carried out in 96-well PCR plates with a total volume of 12.5 μl containing 10 ng of genomic DNA, 1.5 mM MgCI2, 1× PCR reaction buffer, 0.2 mM of each dNTP, 0.3 μM of each primer, 1.5 μM SYTO 9, and 0.5 U of Taq polymerase (Fermentas), and finally, 20 μl of mineral oil was added to prevent evaporation. Two-step amplification was performed on GeneAmp 9700 thermocycler (Applied Biosystems) with the following cycling parameters: 94°C for 5 min initial denaturation, followed by 50 cycles of 94°C 30 s, 58°C 1 min, then 72°C 7 min for incubation and 4°C hold. High Resolution Melting (HRM) analysis for the allelic discrimination was performed on the 96 LightScanner® System (Idaho Laboratories Corp, USA) with the analysis software Call-IT® ( Idaho Laboratories Corp, USA), and the melt was set from 65 to 95°C rising at 0.1°C/s.
Heterozygotes were easily identified by melting peak width and shape. However, the discrimination of two types of homozygous samples for an SNP locus is usually more difficult by simple amplicon melting, because it often has a very similar curved shape. However, homozygous variants could be detected by prior mixing with wild-type DNA [12] , or by adding 15 % of a known homozygous genotype to unknown samples which allows melting curve separation of all three genotypes [13] . We solved this problem by selecting one individual from the far right in normalized melting curves; 1 μl PCR product from this sample was taken and diluted in 1000 μl water, and then 0.2 μl was used as template DNA for the next run of the PCR reaction. Ten microliters of such PCR product was subsequently distributed into all homozygote samples (1:1 volume), and HRM was carried out once more. All homozygotes would be differentiated into heterozygote or homozygote clearly in this way. If the genotype of an individual is the same as the genotype of the template DNA added, it would keep no change; otherwise, it would become heterozygous.
Statistical Analysis of the Affymetrix Genome-Wide Human SNP Array 6.0
To detect significant differences in allele frequency between the patients and controls, chi-square test was used. Firstly, counts of each allele in both groups were derived from ratio of A to B in each array, where A and B are the probe set intensity values of alleles A and B, respectively, according to the Affymetrix coding. The intensity of A and B was obtained from the Affymetrix Birdseed v2 algorithm. Secondly, significant differences in allele frequency were tested using a chi-square test with one degree of freedom by R scripts (www.r-project.org). The genome-wide significance cutoff levels of chromosome 8 were set to P ≤ E−10, P ≤ E−20, and P ≤ E−15 for SCZ119, BPD253, and MDD177, respectively, according to the P value plot of the corresponding disorders ( Supplementary Figs. 1, 2, and 3) .
Our sample has about 80 % power to detect SNP loci with odds ratio (OR) from 2.34 to 3.57 at a significance level of 5 %.
Results
The Genotyping of Four Group Samples in Pooled DNA by Affymetrix 6.0 Microarray A total of 48,753 SNPs on chromosome 8 were genotyped, and a total of 97 SNPs and flanking genes are identified to be associated with SCZ119, BPD253, and MDD177 patients (Table 1 and Fig. 1 ). Outstanding susceptibility genes were identified including CSMD1, NRG1, PXDNL, SGCZ, and TMEM66 in this population. Also, genetic pleiotropy is common across some neuropsychiatric diseases ( Table 1 Thirty-eight SNPs associated with the SCZ119 patients were evaluated in an enlarged sample of 986 SCZ patients. Twentyseven SNPs reached the threshold of P ≤ 1.40E−8 (71.1 %), and 32 reached P ≤ 6.30E−5 (84.2 %) ( Table 2 ).
The Validation of all Associated Genes in the Enlarged Cohort of 986 SCZ Patients
All associated genes revealed were further validated in the enlarged cohort of 986 SCZ patients, and the associations (P ≤ 9.9E−8) of flanking genes for up to 95.9 % of the identified SNPs are replicated (Supplementary Table 1 ).
Discussion
SCZ, BPD, and major MDD are three major devastating mental diseases, each with distinctive and overlapping • Chromosome 8 genes for schizophrenia, bipolar disorder, and major depressive disorder in the population of Shandong province of China.
• SNP associated with schizophrenia or bipolar disorder or major depressive disorder; △ upstream gene of the associated SNP ▽downstream gene of the associated SNP; ◎ intron gene associated with an SNP which is within the gene AD Alzheimer's disease, ADHD attention deficit disorder with hyperactivity, BPD bipolar disorder, MDD major depressive disorder,
SCZ schizophrenia
Bold Outstanding genes epidemiological, symptomatological, and genetic components [14] . However, SCZ has a very large spectrum of symptoms which covers all symptoms of BPD and MDD. According to the present diagnosis classification, these three disorders are belonging to different disease entities, but such classification might be problematic. Kraepelin [15] termed dementia praecox mainly based on the course and prognosis of the illness [16] , and he also identified subtypes of SCZ (hebephrenic, catatonic, and paranoid) (OMIM: 181500). However, subtypes are not etiologically distinct syndromes, as subtypes are not Bbreed true^within families [17] .
Bleuler [18] publicly introduced the term and concept schizophrenia, and his idea was more fully developed in 1911 for the BGroup of Schizophrenias^ [16] .
Hallmayer et al. [19] believed that the inherent heterogeneity originally recognized has been obfuscated in modern diagnostic classifications, which are designed to meet the needs of patient management, not fundamental research, and which may not target phenotypes anchored in the biology of the illness [20] .
Despite the availability of official guidelines, such as the DSM-IV and ICD-10, the controvercy about the relationship of SCZ to BPD and MDD could not be avoided, Fig. 1 The MapView of the candidate genes on chromosome 8 for schizophrenia, bipolar disorder, and major depressive disorder from a genome-wide association study by Affymetrix Genome-Wide Human SNP array 6.0 in the population of Shandong province of China as some puzzling phenomena need explanation; for example, (1) high rates of depression in mothers of SCZ patients were observed [21] . approved for the treatment of SCZ are also proving useful for BPD [23] . According to Ming Taizu Record, the population of Shandong province in the fourteenth century was reduced dramatically due to continuous war, natural disasters (flood, plague, and grasshoppers) and most of the villages were devastated. In contrast, no war or natural disasters took place in Shan Xi province at that time. The two provinces are separated by 1000 km distance and high mountains, serving as a natural barrier. To balance the population distribution in China, the Emperor Yuanzhang Zhu initiated two massive immigration waves from Shan Xi to Shandong province from 1388 to 1389 in order to re-populate that region. It appears that the presentday populations of Shandong province are mostly offspring expanded from different groups of a limited number of ancestors 600 years ago. Therefore, we expect a high degree of homogeneity in the genetic structure of this population.
In this study, a novel logical relationship for the three major mental disorders was revealed by comparing chromosome 8 susceptibility genes comprehensively in the population of Shandong province of China (Table 1 ). Such a relationship might sound ridiculous and absurd; however, if all convergent evidence is considered together, it is highly possible.
Overlapping Genes for SCZ, BPD, and MDD
For SGCZ (Homo sapiens sarcoglycan zeta, Table 1 , nos. 1-3), see highlight in the table. KCNV1 (Homo sapiens potassium voltage-gated channel modifier subfamily V member 1, Table 1 , no. 4) encodes a member of the potassium voltagegated channel subfamily V which is essentially present in the brain and plays a role in regulating neurotransmitter release and neuronal excitability. This gene was associated with SCZ [24] and depression [25] . CSMD3 (Homo sapiens CUB and Sushi multiple domains 3, Table 1 , nos. 4-7) was associated with SCZ, BPD [26] , and MDD [27] . TRPS1 (Homo sapiens transcriptional repressor GATA binding 1, Table 1 , nos. 6-7) encodes a transcription factor that represses GATA-regulated genes. This gene was associated with attention-deficit hyperactivity disorder (ADHD) [28] and posttraumatic stress disorder (PTSD), a potentially chronic and disabling psychiatric disorder that can arise after exposure to trauma [29] .
Overlapping Genes for SCZ and BPD For CSMD1 (Homo sapiens CUB and Sushi multiple domains 1, Table 1 , nos. 8-15) see highlight in the table. XKR6 (Homo sapiens XK related 6, Table 1 , nos. 16-18) was implicated in SCZ and BPD [30] . MTMR9 (Homo sapiens myotubularin related protein 9, Table 1 .16) encodes a myotubularin-related protein which has a significantly altered expression in the superior temporal gyrus of SCZ patients [31] . This gene was associated with proneness to anger [32] and depression [33] .
TUSC3 (Homo sapiens tumor suppressor candidate 3, Table 1 , no. 19) encodes magnesium transporter, and this gene is implicated in SCZ [34] . MSR1 (Homo sapiens macrophage scavenger receptor 1, Table 1 , no. 19) was associated with depression [27] . ASPH (Homo sapiens aspartate beta-hydroxylase, Table 1 , nos. 21-22) is thought to play an important role in calcium homeostasis and is implicated in SCZ by detecting differences in peripheral blood gene expression of individuals with SCZ and their first-degree biological relatives [35] . Also, the differentially methylated promoter was implicated in childhood physical aggression [36] . FABP5 (Homo sapiens fatty acid binding protein 5, Table 1 , nos. 23-24) was associated with SCZ, BPD [37] , and MDD [38] . PMP2 (Homo sapiens peripheral myelin protein 2, Table 1 , nos. 23-24) plays a role in lipid transport protein in Schwann cells, and this gene is related to Alzheimer's disease (AD) [39] . SNX16 (Homo sapiens sorting nexin 16 Table 1 , nos. 25-27) encodes a member of the sorting nexin family. This gene was implicated in SCZ in a genome-wide investigation [34] . RALYL (Homo sapiens RALY RNA binding protein-like, Table 1 , nos. 25-28) is strongly expressed in the brain and is associated with SCZ and epilepsy [40] . SLC26A7 (Homo sapiens solute carrier family 26 member 7, Table 1 , no. 29) was implicated in SCZ [41] and Tourette syndrome [42] . RUNX1T1 (Homo sapiens runt related transcription factor 1, Table 1 , nos. 29-32) was related to SCZ [43] and rodent model of depression [44] . TRIQK (Homo sapiens triple QxxK/R motif containing, Table 1 , nos. 30-32) encodes a novel family of small proteins localized to the endoplasmic reticulum membrane, and this gene is conserved across vertebrates [45] . POU5F1B (Homo sapiens POU class 5 homeobox 1B, Table 1 .33) was implicated in antidepressive agents and ADHD (USCS). MYC (Homo sapiens POU class 5 homeobox 1B, Table 1 , nos. 33-36) was implicated in SCZ [46] and BPD [47] . GSDMC (Homo sapiens gasdermin C, Table 1 , nos. 34-36) was implicated in creativity in music [48] and autism [49] .
Overlapping Genes for SCZ and MDD PSD3 (Homo sapiens pleckstrin and Sec7 domain containing 3, Table 1 , nos. 37-38) was implicated in SCZ [50] and AD [51] . SH2D4A (Homo sapiens SH2 domain containing 4A, Table 1 , no. 38) was associated with ADHD, autism [52] , and AD [53] . DPYSL2 (Homo sapiens dihydropyrimidinase like 2, Table 1 , nos. 39-40) plays a role in synaptic signaling through interactions with calcium channels. This gene was implicated in multiple neuropsychiatric disorders including SCZ [54] and MDD [55, 56] . ADRA1A (Homo sapiens adrenoceptor alpha 1A, Table 1 , nos. 40-41) was associated with SCZ [57] . Also, the differentially modulated antidepressant-like behavior in the mouse suggests that alpha (1A)-ARs may be a useful therapeutic target for the treatment of depression [58] . PPP2CB (Homo sapiens protein phosphatase 2 catalytic subunit beta, Table 1, nos. 42-43) was reported to be implicated in SCZ by gene expression in rodent model [59] and in depression in a rat model [60] . CYP7B1 (Homo sapiens cytochrome P450 family 7 subfamily B member 1, Table 1 , nos. 44-45) was associated with SCZ and AD (UCSC). ARMC1 (Homo sapiens armadillo repeat containing 1, Table 1 , no. 45) was associated with ADHD and autism [52] . SULF1 (Homo sapiens sulfatase 1, Table 1 , no. 46) was implicated in SCZ at different stages of the illness [61, 62] . EYA1 (Homo sapiens EYA transcriptional coactivator and phosphatase 1, Table 1 , nos. 48-49) was implicated in humanspecific transcriptional networks in the brain [63] and associated with sleepiness (UCSC). TRPA1 (Homo sapiens transient receptor potential cation channel subfamily A member 1, Table 1 , nos. 48-49) was associated with SCZ [64, 65] .
Overlapping Genes for BPD and MDD DUSP4 (Homo sapiens dual specificity phosphatase 4, Table 1 , no. 50) was implicated in SCZ (UCSC) and anxiety in the juvenile mouse brain, but depression-like behavior in adults [66] . For TMEM66 (also known as SARAF, Homo sapiens store-operated calcium entry-associated regulatory factor, Table 1 , nos. 50-51), see highlight in the table. CA8 (Homo sapiens carbonic anhydrase VIII, Table 1 , nos. 52-54) was implicated in SCZ [61] , ataxia, and mental retardation [67] . RAB2A (Homo sapiens RAB2A, member RAS oncogene family, Table 1 , no. 53) was implicated in SCZ [35] . CNBD1 (Homo sapiens cyclic nucleotide binding domain containing 1, Table 1 , no. 55) was implicated in ADHD and autism [52] . MMP16 (Homo sapiens matrix metallopeptidase 16, Table 1 , nos. 55-56) was implicated in SCZ, BPD [68] , and depression [44] . RIPK2 (Homo sapiens receptor interacting serine/threonine kinase 2, Table 1 , no. 56) was implicated in neurogenesis and neuropsychiatric disorders [69] . TMEM71 (Homo sapiens transmembrane protein 71) and PHF20L1 (Homo sapiens PHD finger protein 20-like 1, Table 1 , nos. 57-58) were associated with intermale aggressive behavior in BALB/cJ and A/J mice [70] .
Genes for SCZ
FZD3 (Homo sapiens frizzled class receptor 3, Table 1 , no. 60) encodes a transmembrane domain protein that is a receptor for Wnt ligands, and the Wnt-signaling pathway is implicated in a variety of processes in neurodevelopment. This gene is required for formation of the neural crest and for development of major fiber tracts in the CNS and is found to be associated with SCZ and validated in the Chinese population [71] [72] [73] [74] . KCNU1 (Homo sapiens potassium calcium-activated channel subfamily U member 1, Table 1 , no. 61) was implicated in neurological disorders [75] . ZNF703 (Homo sapiens zinc finger protein 703, Table 1 , no. 61) was identified as one of the core genes significantly affected in human MDD and mouse unpredictable chronic mild stress [76] . FGFR1 (Homo sapiens fibroblast growth factor receptor 1, [80] , and rat model of depression [60] . ODF1 (Homo sapiens outer dense fiber of sperm tails 1, Table 1 , no. 67) was implicated in aggressive behavior in BALB/cJ and A/J mice [70] . DPYS (Homo sapiens dihydropyrimidinase, Table 1 , no. 68) encodes a product which catalyzes the conversion of 5,6-dihydrouracil to 3-ureidopropionate in pyrimidine metabolism. OC90 (Homo sapiens otoconin 90, Table 1 , no. 69) was implicated in aggressive behavior in BALB/cJ and A/J mice [70] . FAM135B (Homo sapiens family with sequence similarity 135 member B, Table 1 , nos. 70-72) was associated with autism [81] . LY6K (Homo sapiens lymphocyte antigen 6 complex, locus K, Table 1 , no. 73) was implicated in Parkinson's disease [82] .
Genes for BPD
MFHAS1 (Homo sapiens malignant fibrous histiocytoma amplified sequence 1, [92, 93] .
Genes for MDD
MICU3 (Homo sapiens mitochondrial calcium uptake family member 3, also known as EFHA2, Table 1 , nos. 91-92) may play a role in mitochondrial calcium uptake. Convergent evidence indicates that mitochondrial dysfunction underlines the pathogenesis of psychiatric illness [94] . LZTS1 (Homo sapiens leucine zipper, putative tumor suppressor 1, Table 1 , no. 93) is involved in the regulation of cell growth and is implicated in depression [27, 95] . GFRA2 (Homo sapiens GDNF family receptor alpha 2, Table 1 , no. 93) encodes a receptor for neurturin that plays key roles in the control of neuron survival and differentiation. This gene was associated with MDD [96, 97] . TRPA1 (Homo sapiens transient receptor potential cation channel subfamily A member 1, Table 1 , no. 94) encodes a transient receptor potential cation channel and is associated with SCZ [64, 98] . ZFHX4 (Homo sapiens zinc finger homeobox 4, Table 1 , no. 95) was implicated in autism [99] . PEX2 (Homo sapiens peroxisomal biogenesis factor 2, Table 1 , no. 95) was implicated in the biogenesis of peroxisomes and depression [44] . TPD52 (Homo sapiens tumor protein D52, Table 1 , no. 96) was implicated in suicide [100] and sleep [101] . ZBTB10 (Homo sapiens zinc finger and BTB domain containing 10, Table 1 , no. 96) was associated with hypothyroidism, which is strongly implicated in the pathogenesis of depression [102, 103] . COL22A1 (Homo sapiens collagen type XXII alpha 1, Table 1 , no. 97) was associated with autism [81] , AD, and Parkinson disease (UCSC). KCNK9 (Homo sapiens potassium two pore domain channel subfamily K member 9, Table 1 , no. 97) was implicated in depression by modulating TASK-3 (Kcnk9) potassium channels which have the capacity to regulate arousal cycles and REM sleep changes associated with mood disorders and antidepressant action [104] . [114] and AD [115] .
Conclusion
Firstly, chromosome 8 genes for the three major psychiatric disorders are comprehensively identified in the population of Shandong province of China, and some findings are novel. Secondarily, considering all evidence, both bipolar and major depressive disorder might be subtypes of schizophrenia rather than independent disease entity.
Thirdly, flanking genes for most of the associated SNPs were reported to be associated with neuropsychiatric disorder before.
